9E8-33412-17455
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 363 / AL
- Registered
- 2021-12-01
- Relationship
- Child or adolescent in my care
- Guardian
- 8GB-31175-48442
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-08
Dose 1 — Pfizer-BioNTech
-
2021-11-29
Dose 2 — Pfizer-BioNTech
-
2021-12-01
Registered in v-safe
-
2021-12-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fatigue or tirednessAdult check-in
-
2021-12-02
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-12-08
- 2022-02-28
-
2022-05-26
Dose 3 — Pfizer-BioNTech
-
2022-05-30
Survey response — 6 months, dose 2, dependentMedDRA: Abdominal discomfort — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Some GI discomfort, however unsure if related. Could be from lactose intolerance.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-05-26 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: Some GI discomfort, however unsure if related. Could be from lactose intolerance.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release